Stem cells therapy for spinal cord injury: an overview of clinical trials
Morning grogginess: most research write-ups describe shifting the dose earlier in the evening before lowering the dose itself
Low-quality products may contain impurities, improper copper binding, or degradation products that cause adverse effects while providing minimal benefit
For researchers tracking their metabolic response, metabolic rate changes and energy level shifts become important markers
For the GSSCys assays, either GSH was varied between 50 M and 2.0 mM at fixed GSSCys concentrations (25, 50, 100 and 150 M) or GSSCys was varied between 25 and 200 M at fixed concentrations of GSH (0.05, 0.1, 0.2, 0.3 and 1.0 mM for ScGrx7 or 0.3, 0.5, 1.0 and 2.0 mM for PfGrx)